THURSDAY, Feb. 3, 2022 (HealthDay News) — Stroke is a possible complication of COVID-19, and researchers say they now know when that risk is highest. A new study from the U.S. Centers for Disease Control and Prevention found the risk of COVID-related ischemic stroke appears greatest in the first threeContinue Reading

FRIDAY, Jan. 28, 2022 (HealthDay News) — Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson’s disease, new research shows. Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson’s, and it was suggested that a class of rheumatoid arthritis drugsContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — Taking vitamin D supplements may help stave off psoriasis, rheumatoid arthritis, lupus and other autoimmune diseases, a new study suggests. Previous research has hinted at this connection, but the new study is the first randomized controlled trial to look at what happens whenContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food andContinue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Belly fat is usually unwelcome, but new research suggests it may actually be good for something: relief from foot pain. A small pilot study suggests that an injection of a patient’s own fat cells can help ease the often-excruciating heel pain brought onContinue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — People hospitalized for COVID-19 are not necessarily out of the woods once they’re discharged: Many land in the hospital again in the months afterward, a large U.K. study finds. The researchers found that in the 10 months after leaving the hospital, COVID-19 patientsContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication of the COVID-19 virus and preventing its spread, lab and animal studies show. CBD inhibited the ability of the coronavirus to spread in human lung cell samples, and also suppressedContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — The coronavirus can leave more than 40% of children hospitalized for COVID-19 with headaches and other lingering neurological symptoms, a new study claims. And the kids who developed these headaches or experienced an altered mental status known as acute encephalopathy were more likelyContinue Reading